Human Cytomegalovirus Stimulates Cellular IKK2 Activity and Requires the Enzyme for Productive Replication

Journal of Virology

Volumn 78, Issue 6, 2004, Pages 3190-3195

  Caposio, Patrizia ^a   Dreano, Michel ^b   Garotta, Gianni ^b   Gribaudo, Giorgio ^a   Landolfo, Santo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Serono International SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AS 602868; ENZYME INHIBITOR; I KAPPA B KINASE; I KAPPA B KINASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; VIRUS REACTIVATION; VIRUS REPLICATION;

CELL LINE; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; TRANS-ACTIVATION (GENETICS); VIRUS REPLICATION;

EID: 1542287390     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.6.3190-3195.2004     Document Type: Article

References (29)

1. Abken, H., and B. Reifenrath. 1992. A procedure to standardize CAT reporter gene assay. Nucleic Acids Res. 20:3527.
2. Baldwin, A. S., Jr. 2001. The transcription factor NF-KB and human disease. J. Clin. Investig. 107:3-6.
3. Bhagwat, S., I. B. Brydon, I. Satoh, E. C. O'Leary, J. Leisten, G. S. Firestein, D. L. Boyle, M. Dreano, D. W. Anderson, and C. E. Grimshaw. 2001. The small molecule IKK2 inhibitor SPC839 is efficacious in an animal model of arthritis. Arthritis Rheum. 44:S213.
4. Dixit, V., and T. W. Mak. 2002. NF-KB signaling: many roads lead to Madrid. Cell 111:615-619.
5. Fortunato, E. A., and D. H. Spector. 1999. Regulation of human cytomegalovirus gene expression. Adv. Virus Res. 54:1-128.
6. Fortunato, E. A., A. K. McElroy, V. Sanchez, and D. H. Spector. 2000. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol. 8:111-119.
7. Frelin, C., V. Imbert, E. Griessinger, A. Loubat, M. Dreano, and J.-F. Peyron. 2003. AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in Jurkat leukemic cells. Oncogene 22:8187-8194.
8. Gerna, G., F. Baldanti, M. Zavattoni, A. Sarasini, E. Percivalle, and M. G. Revello. 1992. Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antivir. Res. 19:333-345.
9. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109:81-96.
10. Gribaudo, G., S. Ravaglia, M. Gaboli, M. Gariglio, R. Cavallo, and S. Landolfo. 1995. Interferon-α inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-κB activity. Virology 211: 251-260.
11. Gribaudo, G., S. Ravaglia, L. Guandalini, R. Cavallo, M. Gariglio, and S. Landolfo. 1996. The murine cytomegalovirus immediate-early 1 protein stimulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 promoter. Virus Res. 45:15-27.
12. Griffith, P. D. 2000. Cytomegalovirus, p. 79-115. In A. J. Zuckerman, J. E. Banatvala, and J. R. Pattison (ed.), Principles and practice of clinical virology, 4th ed. Wiley, New York, N.Y.
13. Hiscott, J., H. Kwon, and P. Génin. 2001. Hostile takeovers: viral appropriation of the NF-κB pathway. J. Clin. Investig. 107:143-151.
14. Hummel, M., and M. M. Abecassis. 2002. A model for reactivation of CMV from latency. J. Clin. Virol. 25:S123-S139.
15. Kowalik, T. M., B. Wing, J. S. Haskill, J. C. Azizkhan, A. S. Baldwin, and E. S. Huang. 1993. Multiple mechanisms are implicated in the regulation of NF-κB activity during human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 90:1107-1111.
16. Landolfo, S., M. Gariglio, G. Gribaudo, and D. Lembo. 2003. The human cytomegalovirus. Pharmacol. Ther. 98:269-297.
17. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennet, J. W. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860-866.
18. Mocarski, E. S., and C. T. Courcelle. 2001. Cytomegaloviruses and their replication, p. 2629-2673. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott-Raven, New York, N.Y.
19. Oitzinger, W., R. Hofer-Warbinek, J. A. Schmid, Y. Koshelnick, B. R. Binder, and R. de Martin. 2001. Adenovirus-mediated expression of a mutant IκB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli. Blood 97:1611-1617.
20. Pass, R. F. 2001. Cytomegalovirus, p. 2675-2705. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott-Raven, New York, N.Y.
21. Pauwels, R., J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Hederwijin, J. Desmyter, and E. De Clerq. 1988. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20:309-321.
22. Prosch, S., R. Wuttke, D. H. Kruger, and H. D. Volk. 2002. NF-κB - a potential therapeutic target for inhibition of human cytomegalovirus (re)activation? Biol. Chem. 383:1601-1609.
23. Sagot, Y., P. Sattonet-Roche, S. Bhagwat, C. E. Grimshaw, M. Dreano, and C. Plater-Zyberk. 2001. Two IKK2 inhibitors are orally active small molecules decreasing severity of collagen induced arthritis in DBA/1 mice. Arthritis Rheum. 44:S368.
24. Sambucetti, L. C., J. M. Cherrington, G. W. G. Wilkinson, and E. S. Mocarski. 1989. NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and T cell stimulation. EMBO J. 8:4251-4258.
25. Streblow, D. N., and J. A. Nelson. 2003. Models of HCMV latency and reactivation. Trends Microbiol. 11:293-295.
26. Tato, C. M., and C. A. Hunter. 2002. Host-pathogen interactions: subversion and utilization of the NF-κB pathway during infection. Infect. Immun. 70: 3311-3317.
27. Yamamoto, Y., and R. B. Gaynor. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Investig. 107:135-142.
28. Yurochko, A. D., T. F. Kowalik, S. M. Huong, and E. S. Huang. 1995. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J. Virol. 69:5391-5400.
29. Yurochko, A. D., E. S. Hwang, L. Rasmussen, S. Keay, L Pereira, and E. S. Huang. 1997b. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection. J. Virol. 71:5051-5059.